CSMall Group Ltd
HKEX:1815
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CSMall Group Ltd
HKEX:1815
|
CN |
|
C
|
Cardinal Health Inc
XBER:CLH
|
US |
|
N
|
Novo Nordisk A/S
XBER:NOV
|
DK |
|
G
|
Good Flour Corp
CNSX:GFCO
|
CA |
|
PION Group AB
STO:PION B
|
SE |
|
C
|
Chunghwa Chemical Synthesis & Biotech Co Ltd
TWSE:1762
|
TW |
Cash Flow Statement
Cash Flow Statement
CSMall Group Ltd
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
197
|
58
|
30
|
(44)
|
(31)
|
14
|
8
|
(37)
|
(33)
|
(38)
|
(48)
|
(40)
|
(40)
|
70
|
|
| Depreciation & Amortization |
6
|
0
|
14
|
0
|
12
|
0
|
11
|
0
|
9
|
0
|
10
|
0
|
8
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
87
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(0)
|
12
|
89
|
128
|
50
|
21
|
(8)
|
14
|
6
|
16
|
18
|
42
|
44
|
13
|
|
| Cash Taxes Paid |
57
|
0
|
40
|
0
|
15
|
0
|
5
|
0
|
1
|
0
|
(0)
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
5
|
7
|
6
|
5
|
6
|
6
|
|
| Change in Working Capital |
(488)
|
(39)
|
(9)
|
(149)
|
26
|
(701)
|
(331)
|
321
|
93
|
117
|
(36)
|
(39)
|
19
|
37
|
|
| Cash from Operating Activities |
(285)
N/A
|
31
N/A
|
125
+305%
|
(65)
N/A
|
57
N/A
|
(666)
N/A
|
(320)
+52%
|
299
N/A
|
74
-75%
|
95
+28%
|
(56)
N/A
|
(37)
+34%
|
30
N/A
|
120
+302%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(2)
|
(0)
|
(2)
|
(13)
|
(11)
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(1)
|
(0)
|
(6)
|
(13)
|
|
| Other Items |
(146)
|
(264)
|
(120)
|
168
|
240
|
69
|
(5)
|
(5)
|
2
|
1
|
(3)
|
(13)
|
(16)
|
(9)
|
|
| Cash from Investing Activities |
(148)
N/A
|
(264)
-79%
|
(122)
+54%
|
155
N/A
|
229
+48%
|
69
-70%
|
(5)
N/A
|
(5)
0%
|
2
N/A
|
(0)
N/A
|
(5)
-1 391%
|
(13)
-169%
|
(22)
-69%
|
(22)
-1%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
373
|
0
|
137
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
(3)
|
(8)
|
(19)
|
(28)
|
(26)
|
(15)
|
(4)
|
76
|
92
|
6
|
(5)
|
1
|
(2)
|
|
| Other |
(9)
|
10
|
(8)
|
(8)
|
1
|
(0)
|
(1)
|
(1)
|
10
|
11
|
(0)
|
(3)
|
1
|
4
|
|
| Cash from Financing Activities |
364
N/A
|
7
-98%
|
121
+1 689%
|
111
-9%
|
(27)
N/A
|
(27)
+1%
|
(15)
+42%
|
(5)
+68%
|
87
N/A
|
103
+19%
|
6
-95%
|
(8)
N/A
|
2
N/A
|
2
+27%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
1
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(69)
N/A
|
(225)
-226%
|
124
N/A
|
201
+61%
|
260
+29%
|
(623)
N/A
|
(340)
+45%
|
289
N/A
|
163
-44%
|
198
+22%
|
(56)
N/A
|
(59)
-6%
|
10
N/A
|
100
+925%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(287)
N/A
|
31
N/A
|
123
+299%
|
(78)
N/A
|
46
N/A
|
(666)
N/A
|
(320)
+52%
|
299
N/A
|
74
-75%
|
94
+27%
|
(58)
N/A
|
(38)
+35%
|
24
N/A
|
107
+354%
|
|